Opportunity Information: Apply for PAR 13 386
Apply for PAR 13 386
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.397 Cancer Centers Support Grants.
- This funding opportunity was created on Nov 7, 2013 and posted on Nov 7, 2013.
- Applicants must submit their applications by Jan 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30), listed as PAR-13-386, is a National Institutes of Health (NIH) funding opportunity administered through the National Cancer Institute (NCI). It is designed to provide core, institutional-level support for cancer centers that have earned (or are seeking, consistent with NCI policies) NCI designation. Rather than funding a single research project, the P30 mechanism is meant to strengthen and organize the overall cancer research enterprise at an institution by supporting the infrastructure, shared resources, coordination, and collaborative environment that allow many investigators and research programs to function as an integrated center.
This FOA supports two categories of NCI-designated cancer centers. The first is the Comprehensive Cancer Center. These centers are expected to show meaningful depth and breadth across three major research domains: basic laboratory research, clinical research, and prevention/control/population-based research. A key expectation for comprehensive centers is strong transdisciplinary work that deliberately bridges these areas, for example by connecting discoveries in the lab to clinical testing, and linking clinical insights to prevention, implementation, or population outcomes. The second category is the Cancer Center (often referred to simply as a cancer center rather than comprehensive), which may be more concentrated in basic, clinical, and/or prevention/cancer control/population research, or some combination of these areas, without necessarily demonstrating the same level of breadth across all three domains required for comprehensive designation.
Across both center types, the central purpose is to bring together all of an institution's cancer-related capabilities into one coordinated, high-performing research enterprise. The FOA emphasizes integration: aligning strong laboratory, clinical, and population research programs under a unified structure that can work across departmental and organizational boundaries. In practical terms, this means developing governance, scientific leadership, and program organization that encourages collaboration, reduces duplication, and makes it easier for investigators to work together on cancer problems that require multiple disciplines.
The announcement also makes clear what NCI expects cancer centers supported by CCSGs to accomplish. Centers should serve as major engines of discovery about the nature of cancer and as drivers of improved approaches to cancer prevention, diagnosis, and therapy. They are expected to make significant contributions through the development and maintenance of shared resources that enable high-quality research across the center (for example, centralized cores, specialized facilities, or other common capabilities that individual labs or departments would struggle to sustain alone). In addition, centers are expected to collaborate and coordinate with other NCI-funded programs and investigators, which reflects NCI's broader goal of building connected national research networks rather than isolated local efforts. Finally, dissemination is an explicit expectation: centers should communicate and spread research findings so that the benefits extend beyond the institution and reach the broader community.
From an administrative standpoint, this is a discretionary grant opportunity using the NIH grant funding instrument. The activity category is listed under education/health, and the CFDA number is 93.397 (Cancer Centers Support Grants). There is no cost-sharing or matching requirement stated for this opportunity. The FOA was posted on November 7, 2013, with an original (and current) closing date of January 7, 2017, and an archive date of February 7, 2017, meaning it is no longer active for new submissions under that specific announcement number.
Eligibility includes a range of U.S.-based organizations involved in higher education and nonprofit research. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including both those with and without 501(c)(3) status, as specified). The FOA also explicitly includes several categories of mission-focused institutions, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs). At the same time, the opportunity clearly excludes non-U.S. entities: foreign institutions cannot apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
For applicants and administrators who need the official announcement text, the FOA points to the NIH grants guide page at http://grants.nih.gov/grants/guide/pa-files/PAR-13-386.html (noting that formatting may vary when accessed). For access or linking problems, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is PAR-13-386 (CCSG P30) in plain terms?
PAR-13-386 is a National Institutes of Health (NIH) funding opportunity administered by the National Cancer Institute (NCI) for Cancer Center Support Grants (CCSGs) using the P30 mechanism. It provides core, institutional-level support to strengthen the overall cancer research enterprise at an institution by supporting infrastructure, shared resources, coordination, and a collaborative environment.
Is this grant meant to fund a single research project?
No. The CCSG P30 mechanism is not intended to fund one specific research project. It is designed to support the institutional infrastructure and shared capabilities that help multiple investigators and research programs operate as an integrated cancer center.
Who administers this funding opportunity?
The opportunity is administered through the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH).
What does the CCSG P30 grant support at an institution?
Based on the announcement description, it supports the cancer center's institutional infrastructure such as shared resources (for example, centralized cores or specialized facilities), coordination, governance, scientific leadership, program organization, and activities that promote collaboration and reduce duplication across the institution.
What is the main purpose of the Cancer Center Support Grants (CCSGs)?
The central purpose is to bring together an institution's cancer-related capabilities into one coordinated, high-performing research enterprise, with emphasis on integration across laboratory, clinical, and population-oriented research efforts under a unified structure.
What types of NCI-designated centers are supported under this FOA?
This FOA supports two categories of NCI-designated cancer centers: (1) Comprehensive Cancer Centers and (2) Cancer Centers (often referred to simply as cancer centers rather than comprehensive).
What is expected of a Comprehensive Cancer Center under this FOA?
Comprehensive Cancer Centers are expected to demonstrate meaningful depth and breadth across three major research domains: basic laboratory research, clinical research, and prevention/control/population-based research. A key expectation is strong transdisciplinary work that deliberately bridges these areas.
What is expected of a Cancer Center (non-comprehensive) under this FOA?
A Cancer Center may be more concentrated in basic, clinical, and/or prevention/cancer control/population research (or some combination). It is not required to demonstrate the same breadth across all three domains that is expected for comprehensive designation.
What does the FOA mean by "integration"?
Integration refers to aligning laboratory, clinical, and population research programs under a unified structure that works across departmental and organizational boundaries. In practical terms, it includes governance, scientific leadership, and program organization that encourages collaboration, reduces duplication, and makes it easier for investigators to work together across disciplines.
What outcomes or roles does NCI expect supported centers to fulfill?
The FOA states that centers should serve as major engines of discovery about the nature of cancer and as drivers of improved approaches to cancer prevention, diagnosis, and therapy. They are also expected to maintain shared resources, collaborate and coordinate with other NCI-funded programs and investigators, and disseminate research findings so benefits extend beyond the institution.
Does this opportunity require cost sharing or matching funds?
No cost-sharing or matching requirement is stated for this opportunity in the provided information.
What type of grant is this?
This is a discretionary grant opportunity using the NIH grant funding instrument, and it uses the P30 activity mechanism for Cancer Center Support Grants.
What is the CFDA number for this program?
The CFDA number listed is 93.397 (Cancer Centers Support Grants).
Is this funding opportunity still open for new submissions?
No. The FOA was posted on November 7, 2013, with a closing date of January 7, 2017, and an archive date of February 7, 2017. That means it is no longer active for new submissions under PAR-13-386.
Who is eligible to apply?
Eligibility includes U.S.-based organizations involved in higher education and nonprofit research, including public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including those with and without 501(c)(3) status, as specified).
Are specific mission-focused or minority-serving institutions included as eligible applicants?
Yes. The FOA explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), among the eligible categories listed.
Can foreign institutions apply?
No. Foreign institutions cannot apply under this opportunity.
Are non-domestic components of U.S. organizations eligible?
No. The opportunity states that non-domestic components of U.S. organizations are not eligible.
Are foreign components allowed if defined as such under NIH policy?
No. The FOA indicates that foreign components (as defined by NIH policy) are not allowed.
Where can applicants find the official funding announcement text?
The FOA points to the NIH Grants Guide page at: http://grants.nih.gov/grants/guide/pa-files/PAR-13-386.html. The notice also mentions that formatting may vary when accessed.
Who should be contacted if there are access or linking issues with the FOA page?
The contact listed for access or linking problems is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
What is the broader emphasis of NCI for CCSG-supported centers beyond the institution itself?
The FOA emphasizes collaboration and coordination with other NCI-funded programs and investigators as part of building connected national research networks, and it explicitly expects dissemination of research findings so benefits extend beyond the institution and reach the broader community.
Browse more opportunities from the same category: Education Health
Next opportunity: Evaluation and Administration Coordinating Center for the Low Cost, Pragmatic, Patient Centered Randomized Controlled Intervention Trials (R01)
Previous opportunity: FY10 Railraod Safety Technology Grants (Second Round)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 386
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 386) also looked into and applied for these:
| Funding Opportunity |
|---|
| Low Cost, Pragmatic, Patient Centered Randomized Controlled Intervention Trials (UH2/UH3) Apply for RFA HL 14 019 Funding Number: RFA HL 14 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R41/R42) Apply for PA 13 388 Funding Number: PA 13 388 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44) Apply for PA 13 387 Funding Number: PA 13 387 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program(NCORP) Community Sites (UM1) Apply for RFA CA 13 013 Funding Number: RFA CA 13 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program (NCORP) Research Bases (UM1) Apply for RFA CA 13 012 Funding Number: RFA CA 13 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1) Apply for RFA CA 13 014 Funding Number: RFA CA 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA MH 14 214 Funding Number: RFA MH 14 214 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Indo US Collaborative Program on Affordable Medical Devices (R03) Apply for PAR 13 390 Funding Number: PAR 13 390 Agency: National Institutes of Health Category: Education Health Funding Amount: $75,000 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007 Funding Number: PAR 14 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Identification of Gene Variants for Addiction Related Traits by Next Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) Apply for PAR 14 010 Funding Number: PAR 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| The Palliative Care Research Cooperative (PCRC) Enhancing Sustainability and Building the Science of Palliative Care (R01) Apply for RFA NR 14 003 Funding Number: RFA NR 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Revision Applications for Research on Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 012 Funding Number: PAR 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 011 Funding Number: PAR 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R01) Apply for PA 14 014 Funding Number: PA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21) Apply for PA 14 013 Funding Number: PA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Public Health Impact of the Changing Policy/Legal Environment for Marijuana (R01) Apply for PAS 14 020 Funding Number: PAS 14 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Discovering Novel Targets The Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 14 025 Funding Number: PA 14 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Mechanisms of Brain Development for Substance Use and Dependence (R01) Apply for PA 14 026 Funding Number: PA 14 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 14 031 Funding Number: PAR 14 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R01) Apply for PA 14 029 Funding Number: PA 14 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 386", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.